Global HMO Infant Formula Competitive Landscape Professional Research Report 2025

Research Summary

HMO (Human Milk Oligosaccharide) Infant Formula is a type of infant nutrition designed to closely mimic the composition of human breast milk by incorporating oligosaccharides, which are complex sugars naturally found in human milk. These HMOs play a vital role in promoting gut health and immune function by acting as prebiotics, helping to nourish beneficial gut bacteria and support the development of the infant＇s immune system. Since HMOs are not found in significant amounts in traditional infant formulas, their inclusion in HMO-enhanced formulas aims to offer a closer alternative to breast milk for infants who are not breastfed. HMO Infant Formula is often recommended for infants with specific dietary needs, as it may help improve digestion, reduce the risk of infections, and promote overall health during early development.

According to DIResearch's in-depth investigation and research, the global HMO Infant Formula market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy) etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of HMO Infant Formula. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global HMO Infant Formula market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the HMO Infant Formula market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of HMO Infant Formula industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of HMO Infant Formula Include:

Abbott

Mead Johnson（Reckitt）

Nestlé（Wyeth Nutrition）

Danone (Aptamil)

FrieslandCampina (Friso)

Biostime

Yili Group (Ausnutria Dairy)

HMO Infant Formula Product Segment Include:

2＇-Fucosyllactose (2＇-FL)

Others

HMO Infant Formula Product Application Include:

Online Channel

Specialty Store

Supermarket

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global HMO Infant Formula Industry PESTEL Analysis

Chapter 3: Global HMO Infant Formula Industry Porter’s Five Forces Analysis

Chapter 4: Global HMO Infant Formula Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global HMO Infant Formula Market Size and Forecast by Type and Application Analysis

Chapter 6: North America HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa HMO Infant Formula Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global HMO Infant Formula Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources